RBR-10gx2qhj尚未招募未知
Efficacy of the use of oral melatonin in the treatment of facial melasma in women: a double-blind, randomized, placebo-controlled clinical trial.
Faculdade de Medicina de Botucatu (FMB Unesp)0 个研究点开始时间: 2022年1月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 60Y（—）
- 性别
- Female
入选标准
- •Women with facial melasma 18 to 60 years old, Fitzpatrick's phototypes II to V.
排除标准
- •Patients with other concomitant facial skin diseases, skin diseases with photosensitivity, melasma with mMASI less than 5, history of hypersensitivity to the active substance oral melatonin or to any other component of the formulation described, pregnant or lactating women.
研究者
相似试验
尚未招募
2 期
The evaluation of the effect of oral melatonin in the treatment of oral mucositis and oral pain reduction in patients with upper gastrointestinal tract tumorsIRCT20220426054666N1Karaj University of Medical Sciences98
招募中
3 期
oral melatonin in the treatment of acute respiratory distress syndromeIRCT20130308012743N3Mashhad University of Medical Sciences74
招募中
3 期
The effect of oral melatonin on the quality of life, sleep and blood pressure of renal failure patientsChronic kidney disease.Chronic kidney disease (CKD)IRCT20230205057333N1Yasouj University of Medical Sciences82
尚未招募
3 期
Evaluation of the effect of melatonin on COVID 19IRCT20210411050925N1Iran University of Medical Sciences100
已完成
不适用
The efficacy and safety of melatonin treatment in children with attention deficit hyperactivity disorder (ADHD) and chronic sleep onset insomniaISRCTN47283236niversity Maastricht (The Netherlands)110